Homogeneous photo-Fenton processes at near neutral pH: a review L Clarizia, D Russo, I Di Somma, R Marotta, R Andreozzi Applied Catalysis B: Environmental 209, 358-371, 2017 | 741 | 2017 |
Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study H Gacaferi, GS Collaborative, COVIDSurg Collaborative Anaesthesia 76 (6), 2021 | 537* | 2021 |
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 496 | 2019 |
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism C Durante, E Puxeddu, E Ferretti, R Morisi, S Moretti, R Bruno, F Barbi, ... The Journal of Clinical Endocrinology & Metabolism 92 (7), 2840-2843, 2007 | 457 | 2007 |
The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer D Russo, I Miranda, C Ruocco, Y Battaglia, E Buonanno, S Manzi, ... Kidney international 72 (10), 1255-1261, 2007 | 449 | 2007 |
Coronary artery calcification in patients with CRF not undergoing dialysis D Russo, G Palmiero, AP De Blasio, MM Balletta, VE Andreucci American journal of kidney diseases 44 (6), 1024-1030, 2004 | 386 | 2004 |
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy D Russo, A Pisani, MM Balletta, L De Nicola, FA Savino, M Andreucci, ... American journal of kidney diseases 33 (5), 851-856, 1999 | 362 | 1999 |
Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy D Russo, R Minutolo, A Pisani, R Esposito, G Signoriello, M Andreucci, ... American Journal of Kidney Diseases 38 (1), 18-25, 2001 | 325 | 2001 |
Chronic kidney disease and cardiovascular complications L Di Lullo, A House, A Gorini, A Santoboni, D Russo, C Ronco Heart failure reviews 20, 259-272, 2015 | 322 | 2015 |
Mortality in kidney disease patients treated with phosphate binders: a randomized study B Di Iorio, A Bellasi, D Russo, INDEPENDENT Study Investigators Clinical Journal of the American Society of Nephrology 7 (3), 487-493, 2012 | 313 | 2012 |
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. D Russo, R Minutolo, B Cianciaruso, B Memoli, G Conte, L De Nicola Journal of the American Society of Nephrology 6 (5), 1451-1458, 1995 | 299 | 1995 |
Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment L Di Lullo, A Gorini, D Russo, A Santoboni, C Ronco Cardiorenal medicine 5 (4), 254-266, 2015 | 263 | 2015 |
Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial B Di Iorio, D Molony, C Bell, E Cucciniello, V Bellizzi, D Russo, A Bellasi, ... American Journal of Kidney Diseases 62 (4), 771-778, 2013 | 215 | 2013 |
Activating mutations of the TSH receptor in differentiated thyroid carcinomas. D Russo, F Arturi, M Schlumberger, B Caillou, R Monier, S Filetti, ... Oncogene 11 (9), 1907-1911, 1995 | 194 | 1995 |
Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: a randomized clinical trial B Guida, R Germanò, R Trio, D Russo, B Memoli, L Grumetto, F Barbato, ... Nutrition, Metabolism and Cardiovascular Diseases 24 (9), 1043-1049, 2014 | 184 | 2014 |
Randomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker D Russo, A Testa, L Della Volpe, G Sansone Nephron 55 (3), 254-257, 1990 | 165 | 1990 |
Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis D Russo, S Corrao, Y Battaglia, M Andreucci, A Caiazza, A Carlomagno, ... Kidney international 80 (1), 112-118, 2011 | 164 | 2011 |
Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. Y Nagayama, HL Wadsworth, D Russo, GD Chazenbalk, B Rapoport The Journal of clinical investigation 88 (1), 336-340, 1991 | 162 | 1991 |
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis V Bellizzi, L DeNicola, R Minutolo, D Russo, B Cianciaruso, M Andreucci, ... Nephron 81 (Suppl. 1), 66-70, 1998 | 151 | 1998 |
Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate L Di Lullo, A Bellasi, V Barbera, D Russo, L Russo, B Di Iorio, ... Indian heart journal 69 (2), 255-265, 2017 | 150 | 2017 |